Liposomal bupivacaine: An innovative nonopioid local analgesic for the management of postsurgical pain

Pharmacotherapy

Volumn 32, Issue 9, 2012, Pages

  Candiotti, Keith ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bunionectomy; Exparel; Hemorrhoidectomy; Liposomal bupivacaine; Local analgesia; Nonopioid; Postsurgical pain

Indexed keywords

BUPIVACAINE; PLACEBO;

AREA UNDER THE CURVE; ARTICLE; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DIZZINESS; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; LIPOSOMAL DELIVERY; NAUSEA; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PAINFUL DEFECATION; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE PAIN; PRURITUS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SKIN DISEASE; SOMNOLENCE; VOMITING;

ADULT; ANESTHETICS, LOCAL; BUPIVACAINE; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 84867608464     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1875-9114.2012.01183.x     Document Type: Article

References (33)

1. Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States, 2006. Natl Health Stat Report 2009:1-25.
2. Hall MJ, DeFrances CJ, Williams SN, Golosinskiy A, Schwartzman A. National hospital discharge survey: 2007 summary. Natl Health Stat Report 2010:1-20, 24.
3. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003;97:534-40.
4. Wells N, Pasero C, McCaffery M. Improving the quality of care through pain assessment and management. In: Hughes RG, ed. Patient safety and quality: an evidence-based handbook for nurses, vol. 1. Rockville, MD: Agency for Healthcare Research and Quality, 2008:469-97.
5. Ashburn MA, Caplan RA, Carr DB, et al. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2004;100:1573-81.
6. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 2000;93:1123-33.
7. European Society of Regional Anaesthesia and Pain Therapy. PROSPECT: procedure-specific postoperative pain management. Available from www.postoppain.org. Accessed January 23, 2012.
8. Veterans Health Administration. VHA/DoD clinical practice guideline for the management of postoperative pain. Washington, DC: Veterans Health Administration; 2002.
9. Awad IT, Moore M, Rushe C, Elburki A, O'Brien K, Warde D. Unplanned hospital admission in children undergoing daycase surgery. Eur J Anaesthesiol 2004;21:379-83.
10. Gottschalk A, Smith DS. New concepts in acute pain therapy: preemptive analgesia. Am Fam Physician 2001;63:1979-84.
11. Hospira. Marcaine (bupivacaine HCl) US prescribing information. Lake Forrest, IL. 2009.
12. PDR Staff, eds. Red Book: Pharmacy's fundamental reference, 2012 ed. Montvale, NJ: Thomson Reuters, 2012.
13. New opportunities for hospitals to improve economic efficiency and patient outcomes: The case of Exparel TM, a long-acting non-opioid local analgesic. A Frost & Sullivan White Paper. Available from http://www.frost.com/prod/servlet/cpo/252218999. Accessed June 19, 2012.
14. Palmer PP, Miller RD. Current and developing methods of patient-controlled analgesia. Anesthesiol Clin 2010;28:587-99.
15. Gupta A. Wound infiltration with local anaesthetics in ambulatory surgery. Curr Opin Anaesthesiol 2010;23:708-13.
16. White PF, Ardeleanu M, Schooley G, Burch RM. Pharmacokinetics of depobupivacaine following infiltration in patients undergoing two types of surgery and in normal volunteers. International Anesthesia Research Society Annual Meeting, San Diego, CA, March 14-17, 2009.
17. Gorfine SR, Onel E, Patou G, Krivokapic ZV. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum 2011;54:1552-9.
18. ® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther 2011;28:776-88.
19. Bergese S, Candiotti K, Gorfine S. The efficacy of EXPAREL, a multivesicular liposomal extended-release bupivacaine. Presented at the 26th Annual Meeting of the Society for Ambulatory Anesthesia, San Antonio, TX, May 5-8, 2011.
20. Pacira Pharmaceuticals Inc. EXPAREL (bupivacaine liposome injectable suspension) prescribing information. Parsippany, NJ; 2011.
21. Viscusi G, Sinatra R. The safety of Exparel, a multi-vesicular liposomal extended-release bupivacaine. Presented at the International Anesthesia Research Society Annual Meeting, Vancouver, Canada, May 21-24, 2011.
22. Bergese SD, Onel E, Morren M, Morganroth J. Bupivacaine extended-release liposome injection exhibits a favorable cardiac safety profile. Reg Anesth Pain Med 2012;37(2): 145-51.
23. Nasseem A, Harada T, Wang D, et al. Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers. J Clin Pharmacol 2011 [Epub ahead of print, Nov. 4, 2011]. doi: 10.1177/0091270011419853.
24. Smoot JD, Bergese SD, Onel E, Williams HT, Hedden W. The efficacy and safety of DepoFoam bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammoplasty: a randomized, double-blind, active-control study. Aesthet Surg J 2012;32:69-76.
25. Onel E, Warnott K, Lambert W, Patou G. Pharmacokinetics of depobupivacaine (EXPAREL), a novel bupivacaine extended-release liposomal injection, in volunteers with moderate hepatic impairment. Presented at the Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Dallas, TX, March 2-5, 2011.
26. Miller H, Terem T, Kheladze K, Mosidze B. A single administration of depobupivacaine intraoperatively provides three-day analgesia and reduction in use of rescue opioids in patients undergoing hemorrhoidectomy. Presented at the Annual Meeting of the American Society of Colon and Rectal Surgeons, Hollywood, FL, May 2-6, 2009.
27. Onel E, Miller H, Patou G, White PF. EXPAREL, a liposomal bupivacaine local analgesic, extends pain relief and decreases opioid use. Presented at the Annual Meeting of the American Society of Anesthesiologists, San Diego, CA, October 16-20, 2010.
28. Minkowitz HS, Onel E, Patronella CK, Smoot JD. A two-year observational study assessing the safety of DepoFoam bupivacaine after augmentation mammoplasty. Aesthet Surg J 2012; 32(2):186-93.
29. White PF, Schooley G, Ardeleanu M. Analgesia following a single administration of depobupivacaine intraoperatively in patients undergoing inguinal herniorraphy: preliminary doseranging studies. Presented at the Annual Meeting of the International Anesthesia Research Society, San Diego, CA, March 14-17, 2009.
30. Langford RM, Chappell GM, Karrasch JA. A single administration of depobupivacaine intraoperatively results in prolonged detectable plasma bupivacaine and analgesia in patients undergoing inguinal hernia repair. Presented at the 62nd Postgraduate Assembly in Anesthesiology, New York, NY, December 12-16, 2008.
31. Bramlett KW, Jones RK, Pink M, Pink T. A single administration of depobupivacaine intraoperatively provides analgesia and reduction in use of rescue opiates compared with bupivacaine HCl in patients undergoing total knee arthroplasty [poster]. Presented at the XXXVI Biennial World Congress of the International College of Surgeons, Vienna, Austria, December 3-6, 2008.
32. Oderda GM, Evans RS, Lloyd J, et al. Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manage 2003;25:276-83.
33. Meissner B, Nelson W, Hicks R, et al. The rate and costs attributable to intravenous patient-controlled analgesia errors. Hosp Pharm 2009;44:312-24.